Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xifeng Wu

Showing results (11-20 of 583) with videos related to

Pageof 59
Sort By:
Current Opinion in Urology|August 2, 2008
Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactionsYohei Horikawa, Jian Gu, Xifeng Wu
Cancer|October 12, 2013
Development and validation of risk models and molecular diagnostics to permit personalized management of cancerXia Pu, Yuanqing Ye, Xifeng Wu
Current Pharmaceutical Design|October 25, 2012
MicroRNA in the pathogenesis and prognosis of esophageal cancerJian Gu, Yan Wang, Xifeng Wu
Trends in Cancer|November 17, 2023
Big data and artificial intelligence in cancer researchXifeng Wu, Wenyuan Li, Huakang Tu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2005
Integrative epidemiology: from risk assessment to outcome predictionMargaret R Spitz, Xifeng Wu, Gordon Mills
Cancer Research|April 19, 2007
Mutagen sensitivity: a genetic predisposition factor for cancerXifeng Wu, Jian Gu, Margaret R Spitz
Nature Reviews. Genetics|July 22, 2004
Assessing the function of genetic variants in candidate gene association studiesTimothy R Rebbeck, Margaret Spitz, Xifeng Wu
Urologic Oncology|June 30, 2012
Germline prognostic markers for urinary bladder cancer: obstacles and opportunitiesDavid W Chang, Jian Gu, Xifeng Wu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
Prostate stem cell antigen: a Jekyll and Hyde molecule?Norihisa Saeki, Jian Gu, Teruhiko Yoshida, et al.
Oncotarget|July 28, 2016
Genetic variations in apoptosis pathway and the risk of ovarian cancerHui Xie, Wade Tao, Xifeng Wu, et al.
Pageof 59

Showing results (11-20 of 583) with videos related to

Sort By:
Pageof 59
Current Opinion in Urology|August 2, 2008
Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactionsYohei Horikawa, Jian Gu, Xifeng Wu
Cancer|October 12, 2013
Development and validation of risk models and molecular diagnostics to permit personalized management of cancerXia Pu, Yuanqing Ye, Xifeng Wu
Current Pharmaceutical Design|October 25, 2012
MicroRNA in the pathogenesis and prognosis of esophageal cancerJian Gu, Yan Wang, Xifeng Wu
Trends in Cancer|November 17, 2023
Big data and artificial intelligence in cancer researchXifeng Wu, Wenyuan Li, Huakang Tu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2005
Integrative epidemiology: from risk assessment to outcome predictionMargaret R Spitz, Xifeng Wu, Gordon Mills
Cancer Research|April 19, 2007
Mutagen sensitivity: a genetic predisposition factor for cancerXifeng Wu, Jian Gu, Margaret R Spitz
Nature Reviews. Genetics|July 22, 2004
Assessing the function of genetic variants in candidate gene association studiesTimothy R Rebbeck, Margaret Spitz, Xifeng Wu
Urologic Oncology|June 30, 2012
Germline prognostic markers for urinary bladder cancer: obstacles and opportunitiesDavid W Chang, Jian Gu, Xifeng Wu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
Prostate stem cell antigen: a Jekyll and Hyde molecule?Norihisa Saeki, Jian Gu, Teruhiko Yoshida, et al.
Oncotarget|July 28, 2016
Genetic variations in apoptosis pathway and the risk of ovarian cancerHui Xie, Wade Tao, Xifeng Wu, et al.
Pageof 59